Blog
RSS FeedPosted by Michael Wonder on 09 Sep 2024
Celltrion’s Stelara biosimilar secures UK approval
4 September 2024 - Celltrion said its Stelara (ustekinumab) biosimilar, Steqeyma, received marketing authorisation from the UK MHRA. ...
Posted by Michael Wonder on 15 Aug 2024
Zolbetuximab approved to treat adults with stomach or gastro-oesophageal junction cancer
14 August 2024 - A new targeted cancer treatment, given in combination with a standard chemotherapy, for adults with stomach (gastric) ...
Posted by Michael Wonder on 26 Jul 2024
MHRA approves GLP-1 receptor agonist semaglutide to reduce risk of serious heart problems in obese or overweight adults
23 July 2024 - Semaglutide is the first weight loss drug approved in the UK as a preventative treatment for those ...
Posted by Michael Wonder on 02 Mar 2024
MHRA grants first approval via the new International Recognition Procedure in 30 days
1 March 2024 - Launched in January 2024, IRP aims to further help bring life-saving new medicines to UK patients without ...
Posted by Michael Wonder on 22 Feb 2024
UK's MHRA revokes authorisation for Novartis' sickle cell drug
21 February 2024 - Britain's health regulator said on Wednesday it had revoked a conditional marketing authorisation for Novartis' sickle ...
Posted by Michael Wonder on 29 Jan 2024
Rezzayo approved to treat adult patients with invasive candidiasis
29 January 2024 - The MHRA has today approved the medicine Rezzayo (rezafungin) to treat a fungal infection called invasive candidiasis. ...
Posted by Michael Wonder on 15 Jan 2024
Santhera receives approval for Agamree (vamorolone) as a treatment for Duchenne muscular dystrophy in the United Kingdom
12 January 2024 - Launches of Agamree in Europe, with Germany taking the lead, are planned to start in Q1, ...
Posted by Michael Wonder on 03 Jan 2024
MHRA’s new international recognition procedure goes live from 1 January 2024
2 January 2024 - In partnership with other global regulators, the international recognition procedure is expected to further help bring life-saving ...
Posted by Michael Wonder on 04 Aug 2017
How much should we spend on health care?
3 August 2017 - What’s the right amount of spending on health care? And how does the UK’s spending compare ...
Posted by Michael Wonder on 23 Sep 2015
No evidence that £1bn Cancer Drugs Fund has helped patients, says watchdog
17 September 2015 - There is no way of knowing whether the Cancer Drugs Fund, which has cost the NHS £1bn ...
Posted by Michael Wonder on 16 Sep 2015
NICE proposes further research for Dupuytren’s contracture treatment
16 September 2015 - NICE has today confirmed its previous final draft guidance not to recommend collagenase clostridium histolyticum (Xiapex, Swedish ...
Posted by Michael Wonder on 26 Aug 2015
NICE green light for Sankyo's bloodthinner Lixiana
25 August 2015 - The National Institute for Health and Care Excellence has issued a final recommendation for Sankyo’s blood thinner ...
Posted by Michael Wonder on 26 Aug 2015
Final NICE green light for Takeda's Entyvio
26 August 2015 - Crohn’s disease patients can now get routine access to treatment with Takeda’s biologic Entyvio on the National ...